Colloids and Surfaces B: Biointerfaces 2008-08-01

Investigation of the role of electrolytes and non-electrolytes on the cloud point and dye solubilization in antidepressant drug imipramine hydrochloride solutions.

Md Sayem Alam, Kabir-Ud-Din

Index: Colloids Surf. B Biointerfaces 65(1) , 74-9, (2008)

Full Text: HTML

Abstract

Antidepressant drug imipramine hydrochloride (IMP) is amphiphilic which shows surfactant-like behavior in aqueous solutions. We have studied the effect of adding electrolytes and non-electrolytes on the micellar behavior of IMP by making cloud point (CP) and dye solubilization measurements. The CP of a 100mM IMP solution (prepared in 10mM sodium phosphate (SP) buffer) was found to decrease with increasing pH, both in the absence as well as presence of added salts. Increase in pH increased the visible absorbance of Sudan III dye solubilized in the drug micelles, implying micellar growth. Addition of increasing amounts of salts to 100mM IMP solutions (at pH 6.7) caused continuous increase in CP due to micellar growth. On the basis of these studies, the binding-effect orders of counter- and co-ions have been deduced, respectively, as: Br(-)>Cl(-)>F(-) and Li(+)

Related Compounds

  • Ammonium bromide
  • Lithium bromide

Related Articles:

Mesoporous silica coated gold nanorods loaded doxorubicin for combined chemo-photothermal therapy.

2014-08-15

[Int. J. Pharm. 470(1-2) , 1-7, (2014)]

Dispersive micro-solid-phase extraction of benzodiazepines from biological fluids based on polyaniline/magnetic nanoparticles composite.

2014-09-24

[Anal. Chim. Acta 844 , 80-9, (2014)]

Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model.

2015-01-01

[Scand. J. Immunol. 81(1) , 31-8, (2014)]

5-Aminosalicylic acid attenuates allergen-induced airway inflammation and oxidative stress in asthma.

2014-12-01

[Pulm. Pharmacol. Ther. 29(2) , 209-16, (2014)]

Cationic lipid-assisted polymeric nanoparticle mediated GATA2 siRNA delivery for synthetic lethal therapy of KRAS mutant non-small-cell lung carcinoma.

2014-08-04

[Mol. Pharm. 11(8) , 2612-22, (2014)]

More Articles...